Pulmonary cavitary disease due to Mycobacterium xenopi.
Infect Med (Beijing)
; 1(1): 63-66, 2022 Mar.
Article
en En
| MEDLINE
| ID: mdl-38074974
ABSTRACT
Non-tuberculous mycobacteria are a significant cause of pulmonary infections worldwide and can be clinically challenging. Mycobacterium xenopi (M. xenopi) has a low pathogenicity and usually requires immunosuppression or lung diseases. We describe herein a scarce case of pulmonary cavitary disease attributed to M. xenopi in a 57-year-old Caucasian patient with underlying structural lung disease successfully treated with rifampicin, ethambutol, clarithromycin, and amikacin.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Infect Med (Beijing)
Año:
2022
Tipo del documento:
Article
País de afiliación:
Francia